This tumour, initially described by Enzinger as "clear cell sarcoma of tendons and aponeuroses", is of uncertain origin, but its immunohistochemical profile shows its melanocytic nature; however it has no genetic relationship with the cutaneous malignant melanoma.
Clinics and pathology

Embryonic origin
Being of melanocytic origin, this tumour should be classified as a neuroectodermal tumour.
Etiology
Unknown.
Epidemiology
It is a very rare tumour representing a minority of all soft tissue sarcomas.
Clinics
The malignant melanoma of soft parts (MMSP) preferentially occurs in young adults, between ages of 20 and 40 years; the tumour develops mainly in the extremities, especially the legs (foot, knee, heel, ankle); it is usually deeply seated, and often bound to tendons and aponeuroses.
Pathology
The tumours show compact nests and strands of round or fusiform cells with a clear cytoplasm, separated by fibrocollagenous tissue often connected to adjacent tendons or aponeuroses; mitotic index is generally low; the cells of nearly all cases express S-100 protein and the melanoma-associated antigen HMB45.
Treatment
The treatment protocols vary greatly according to the institutions; however, the melanoma of soft parts is a highly malignant tumour which requires surgical excision combined with radiotherapy and/or chemotherapy.
Evolution
Many patients develop recurrences and regional and distant metastases, in lymph nodes, lung, and bones; in the series of Enzinger, the average time between diagnosis and recurrence was 2.6 years, between diagnosis and metastasis, 3.5 years.
Prognosis
The prognosis is poor; in the series of 115 patients studied by Enzinger, 46% had died; of the 62 living patients, 21 experienced one or more recurrences, and 7 had a metastatic disease.
Cytogenetics
Cytogenetics Morphological
This tumour is characterised by the presence of a chromosome translocation t(12;22)(q13;q12), which involves genes ATF-1, on chromosome 12, and EWS, on chromosome 22.
Genes involved and proteins
EWSR1
Location 22q12
